Denmark· DK-28106647121
CAMZYOS
A mavacamten product containing mavacamten, registered in Denmark by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Mavacamten is registered in 15 of 19 countries.
Countries holding a registration under ATC C01EB24 (mavacamten), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Mavacamten · ATC C01EB24
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mavacamten costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mavacamten · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$118.52
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Mavacamten
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Denmark (DK)
- ATC code
- C01EB24
- ATC class
- Mavacamten
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106647121
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C01EB24
Mavacamten, as other registers publish it.
- IcelandCamzyosBristol-Myers Squibb Pharma EEIG*
- IcelandCamzyosBristol-Myers Squibb Pharma EEIG*
- PolandCamzyosBristol-Myers Squibb Pharma EEIG
- IcelandCamzyosBristol-Myers Squibb Pharma EEIG*
- NorwayCamzyosBristol-Myers Squibb Pharma EEIG
- PolandCamzyosBristol-Myers Squibb Pharma EEIG
- PolandCamzyosBristol-Myers Squibb Pharma EEIG
- SwitzerlandCamzyos
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccb18f77-5055-4857-bd75-1937d5d5d25f GET /v1/drugs/ccb18f77-5055-4857-bd75-1937d5d5d25f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, hårde",
"source": "dkma",
"strength": "10 mg",
"auth_role": "MOD",
"dk_drugid": "28106647121",
"substance": "Mavacamten",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45103"
}See everything about mavacamten.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.